Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-22 4:31 pm Purchase |
2022-06-16 | 13G | Instil Bio, Inc. TIL |
RA Capital Management, L.P. | 383,540 5.930% |
383,540 (New Position) |
Filing History |
| 2022-06-21 4:35 pm Purchase |
2009-02-28 | 13D | Wave Life Sciences Ltd. WVE |
RA Capital Management, L.P. | 17,269,811 19.990% |
9,441,354 (+120.60%) |
Filing History |
| 2022-06-03 5:11 pm Sale |
2022-06-02 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 136,515 4.700% |
-111,277 (-44.91%) |
Filing History |
| 2022-05-31 5:31 pm Sale |
2022-05-26 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 247,792 8.530% |
-74,020 (-23.00%) |
Filing History |
| 2022-05-25 5:12 pm Sale |
2022-05-23 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 321,812 11.080% |
-114,773 (-26.29%) |
Filing History |
| 2022-05-25 4:29 pm Purchase |
2022-05-15 | 13G | Celcuity Inc. CELC |
RA Capital Management, L.P. | 1,486,471 9.900% |
1,486,471 (New Position) |
Filing History |
| 2022-05-20 4:30 pm Purchase |
2022-05-10 | 13D | PepGen Inc. PEPG |
RA Capital Management, L.P. | 8,131,952 36.300% |
8,131,952 (New Position) |
Filing History |
| 2022-05-16 4:33 pm Sale |
2022-05-16 | 13G | Zogenix, Inc. ZGNX |
RA Capital Management, L.P. | 0 0.000% |
-3,333,700 (Position Closed) |
Filing History |
| 2022-05-16 4:32 pm Sale |
2022-05-16 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
RA Capital Management, L.P. | 0 0.000% |
-3,115,008 (Position Closed) |
Filing History |
| 2022-05-16 4:31 pm Sale |
2022-05-16 | 13G | Bolt Biotherapeutics, Inc. BOLT |
RA Capital Management, L.P. | 0 0.000% |
-2,378,325 (Position Closed) |
Filing History |
| 2022-05-16 4:30 pm Sale |
2022-05-16 | 13G | Olema Pharmaceuticals, Inc. OLMA |
RA Capital Management, L.P. | 0 0.000% |
-2,150,404 (Position Closed) |
Filing History |
| 2022-05-02 4:30 pm Purchase |
2022-04-28 | 13D | Nkarta, Inc. NKTX |
RA Capital Management, L.P. | 7,832,340 16.200% |
2,227,211 (+39.74%) |
Filing History |
| 2022-04-28 4:58 pm Purchase |
2022-04-18 | 13G | NanoString Technologies, Inc. NSTGQ |
RA Capital Management, L.P. | 3,517,694 7.700% |
3,517,694 (New Position) |
Filing History |
| 2022-04-25 4:30 pm Purchase |
2022-04-13 | 13G | Aclaris Therapeutics, Inc. ACRS |
RA Capital Management, L.P. | 4,398,453 7.100% |
4,398,453 (New Position) |
Filing History |
| 2022-04-21 4:30 pm Purchase |
2022-04-11 | 13G | Veru Inc. VERU |
RA Capital Management, L.P. | 7,900,000 9.870% |
7,900,000 (New Position) |
Filing History |
| 2022-04-08 4:31 pm Purchase |
2022-03-29 | 13G | AN2 Therapeutics, Inc. ANTX |
RA Capital Management, L.P. | 3,666,663 19.600% |
3,666,663 (New Position) |
Filing History |
| 2022-04-01 4:30 pm Sale |
2022-03-30 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 436,585 15.030% |
-1,877 (-0.43%) |
Filing History |
| 2022-03-24 4:30 pm Purchase |
2022-03-14 | 13G | Standard BioTools Inc. LAB |
RA Capital Management, L.P. | 4,651,177 6.000% |
4,651,177 (New Position) |
Filing History |
| 2022-03-14 5:04 pm Purchase |
2022-03-10 | 13D | Cytek Biosciences, Inc. CTKB |
RA Capital Management, L.P. | 13,139,327 9.800% |
2,057,164 (+18.56%) |
Filing History |
| 2022-02-28 5:29 pm Purchase |
2022-02-28 | 13D | Cytek Biosciences, Inc. CTKB |
RA Capital Management, L.P. | 11,082,163 8.300% |
1,475,135 (+15.35%) |
Filing History |